The frontiers in gynecologic cancer management: Exploring the new hope to manage women with endometrial cancer by immunochemotherapy

Taiwanese Journal of Obstetrics and Gynecology, Год журнала: 2025, Номер 64(3), С. 404 - 406

Опубликована: Май 1, 2025

Язык: Английский

Endometrial cancer: Part II. Multimodality treatment of uterine high-grade serous carcinoma (clinical course II)

Taiwanese Journal of Obstetrics and Gynecology, Год журнала: 2025, Номер 64(3), С. 425 - 433

Опубликована: Май 1, 2025

The part II (clinical course I) of endometrial cancer (EC) describing the complex clinical (initial treatment and therapy for first recurrence at both local-regional distant metastatic sites) a 66-year-old woman with uterine high-grade serous carcinoma (HGSC, post-curettage diagnosis) after minimally invasive surgery (MIS) treatment-confirmed absence residual tumor. In I, we discussed recent trend in using MIS treating early-stage EC patients, regardless whether histologic types are classified, as well rationale absent following postoperative adjuvant due to no tumor gross specimen complete staging surgery. patient had multiple recurrences loco-regional sites 22-month disease-free survival (DFS). After salvage therapy, including incomplete cytoreductive symptom control, chemotherapy, radiotherapy final systemic durable response period (10-month plus 9 months 2nd progression-free [PFS]). current report is subsequent this II), which further managed second based on modality achieve significantly improve quality life.

Язык: Английский

Complex tumor microenvironment of endometrial cancer

Taiwanese Journal of Obstetrics and Gynecology, Год журнала: 2025, Номер 64(3), С. 407 - 409

Опубликована: Май 1, 2025

Язык: Английский